‘Parts of tigers, rhinos being used in Chinese meds’

A probe by the Environmental Investigation Agency (EIA) has found that body parts of leopards and pangolins, which are highly trafficked and endangered mammals, are used in at least 88 traditional Chinese medicines. The medicines, manufactured by 72 Chinese firms and licensed by the National Medical Products Administration (NMPA), also contain tiger and rhino parts, in violation of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES). The report also identifies 62 banks and financial institutions that have invested in Chinese pharmaceutical groups manufacturing these products.